Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.

Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.

Item
http://www.wikidata.org/entity/Q37612292
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.Pharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors.Tissue concentration of systemically administered antineoplastic agents in human brain tumors.Development and validation of an anodic stripping voltammetric method for determination of Zn(2+) ions in brain microdialysate samples.Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applicationsSystemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissueRecent advances in histamine H3 receptor antagonists/inverse agonists.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Overview of experimental models of the blood-brain barrier in CNS drug discovery.Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.Multiple sclerosis and the blood-central nervous system barrier.Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes
P2860

Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.

Item
http://www.wikidata.org/entity/Q37612292
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@en
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@nl
type
label
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@en
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@nl
prefLabel
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@en
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698